Evidence map›Paper›PMID 39537364›Full record

ArticleACS infectious diseases2024

Eradication of

Sweta Roy, Zeynep S Cakmak, Salma Mahmoud, Mahsa Sadeghzadeh, Guirong Wang, Dacheng Ren

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Phage-Based Approaches to ChronicAntibiotics (Basel, Switzerland) · 2026
    Review
  4. Review
  5. Review
  6. Fexinidazole and Corallopyronin A targetbioRxiv : the preprint server for biology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sweta RoyDepartment of Biomedical and Chemical Engineering, Syracuse University, Syracuse, New York 13244, United States.
Zeynep S CakmakDepartment of Biomedical and Chemical Engineering, Syracuse University, Syracuse, New York 13244, United States.
Salma MahmoudDepartment of Surgery, SUNY Upstate Medical University, Syracuse, New York 13210, United States.
Mahsa SadeghzadehDepartment of Surgery, SUNY Upstate Medical University, Syracuse, New York 13210, United States.
Guirong WangDepartment of Surgery, SUNY Upstate Medical University, Syracuse, New York 13210, United States.
Dacheng RenDepartment of Biomedical and Chemical Engineering, Syracuse University, Syracuse, New York 13244, United States.ORCID 0000-0002-6517-906X

Funding

Mechanisms of differential susceptibility of human SP-B genetic variants to pneumonia and lung injuryR01HL136706 · NHLBI · UPSTATE MEDICAL UNIVERSITY · PI WANG, GUIRONG · 2017 to 2020
$1.6M
Controlling Catheter-Associated Urinary Tract Infections Using Smart Catheters with Rationally Designed Active TopographiesR01EB030621 · NIBIB · SYRACUSE UNIVERSITY · PI REN, DACHENG · 2021 to 2024
$1.5M
Roles of human surfactant collectin variants in the susceptibility of COVID-19R21AI171574 · NIAID · UPSTATE MEDICAL UNIVERSITY · PI WANG, GUIRONG · 2022 to 2023
$448k
Optogenetic Control of Bacterial Persistence to Study Biomaterial InfectionsR21AI185651 · NIAID · UNIVERSITY OF TENNESSEE KNOXVILLE · PI REN, DACHENG · 2024 to 2025
$441k
NHLBI NIH HHS R01 HL136706NIAID NIH HHS R21 AI171574NIAID NIH HHS R21 AI185651NIBIB NIH HHS R01 EB030621
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Bacterial AgentsBiofilmsPseudomonas aeruginosaPseudomonas InfectionsTetracyclinesAnimalsDisease Models, AnimalFemaleMiceMicrobial Sensitivity TestsAnti-Bacterial AgentseravacyclineTetracyclinesantibioticbacterial pneumonia modelbiofilmeravacyclineP. aeruginosapersister

Identifiers

PMID39537364
PMCPMC11650763

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.